Amryt Pharma Plc - ADR logo

Amryt Pharma Plc - ADR Share Price Today (NASDAQ: AMYT)

Amryt Pharma Plc - ADR share price is $0 & ₹0.00 as on 10 Apr 2023 IST

-14.7

(-100%)

Market is closed - opens 7 PM, 16 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 11 Apr 2023

View live Amryt Pharma Plc - ADR share price in Dollar and Rupees. Guide to invest in Amryt Pharma Plc - ADR stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Amryt Pharma Plc - ADR, along with analyst recommendations, forecasts, and comprehensive financials.

Amryt Pharma Plc - ADR (AMYT) Key Statistics

in dollars & INR

Previous Close
$14.7
Open
$14.71
Market Capitalization
$943.4M
Today's Volume
$2.4M
Revenue TTM
$243.6M
EBITDA
$-73.8M
Earnings Per Share (EPS)
$0.37
PE Ratio
39.7
Dividend Yield
0.0%
Profit Margin
-0.32%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-0.25%

How to invest in Amryt Pharma Plc - ADR Stock (AMYT) from India?

It is very easy for Indian residents to invest directly in Amryt Pharma Plc - ADR from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Amryt Pharma Plc - ADR stock in both Indian Rupees (INR) and US Dollars (USD). Search for Amryt Pharma Plc - ADR or AMYT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Amryt Pharma Plc - ADR or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Amryt Pharma Plc - ADR shares which would translate to null fractional shares of Amryt Pharma Plc - ADR as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Amryt Pharma Plc - ADR, in just a few clicks!

Global Institutional Holdings in Amryt Pharma Plc - ADR

  • Athyrium Capital Management LP

    13.81%

  • Highbridge Capital Management, LLC

    9.88%

  • Stonepine Capital Management Llc

    9.88%

  • Rubric Capital Management LP

    5.61%

  • Mpm Asset Management, LLC

    4.16%

  • EdgePoint Investment Group, Inc.

    3.55%

Analyst Recommendation on Amryt Pharma Plc - ADR

Rating
Trend

Buy

    100%Buy

    0%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Amryt Pharma Plc - ADR(by analysts ranked 0 to 5 stars)

About Amryt Pharma Plc - ADR

Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
Organization
Amryt Pharma Plc - ADR
Employees
289
CEO
Dr. Joseph A. Wiley
Industry
Health Technology

Important FAQs about investing in AMYT Stock from India :

Can Indians buy Amryt Pharma Plc - ADR shares?

Yes, Indians can invest in the Amryt Pharma Plc - ADR (AMYT) from India.

With INDmoney, you can buy Amryt Pharma Plc - ADR at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Amryt Pharma Plc - ADR at zero transaction cost.

How can I buy Amryt Pharma Plc - ADR shares from India?

It is very easy to buy Amryt Pharma Plc - ADR from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Amryt Pharma Plc - ADR (AMYT) be purchased?

Yes, you can buy fractional shares of Amryt Pharma Plc - ADR with INDmoney app.

What are the documents required to start investing in Amryt Pharma Plc - ADR stocks?

To start investing in Amryt Pharma Plc - ADR, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Amryt Pharma Plc - ADR?

Today's market capitalisation of Amryt Pharma Plc - ADR AMYT is 943.4M

Who is the Chief Executive Officer (CEO) of Amryt Pharma Plc - ADR ?

Dr. Joseph A. Wiley is the current Chief Executive Officer (CEO) of Amryt Pharma Plc - ADR.